Home » Topics » Regulatory » EMA

EMA
RSS

COMP recommends orphan drug status for Nektar Therapeutics' lead oncology agent in ovarian cancer

July 19, 2011

BioAlliance gives update on Livatag and Clonidine Lauriad

July 14, 2011

Advanced Cell Technology's RPE cells gain E.U. orphan drug status in Stargardt's macular dystrophy

July 7, 2011

CHMP adopts positive opinion on new Kiovig indication in multifocal motor neuropathy

July 1, 2011

CHMP recommends approval of Eurartesim for malaria

June 30, 2011

EMA accepts tesamorelin MAA for review

June 29, 2011

Amgen obtains positive CHMP opinion on Vectibix after reexamination

June 29, 2011

CHMP adopts positive opinion on Buccolam

June 29, 2011

CHMP issues negative opinion on Bronchitol for cystic fibrosis

June 28, 2011

CHMP issues negative opinion on Glybera MAA

June 28, 2011

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...